Table of contents
Volume 97, Issue 8
Published online 16 October 2007 (1021-1188)
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor |
Corrigendum
Clinical Studies
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer FREE
W Schippinger, H Samonigg, R Schaberl-Moser, R Greil, R Thödtmann, J Tschmelitsch, M Jagoditsch, G G Steger, R Jakesz, F Herbst, F Hofbauer, H Rabl, P Wohlmuth, M Gnant and J Thaler for the Austrian Breast and Colorectal Cancer Study Group
Br J Cancer 97: 1021-1027; advance online publication, September 25, 2007; doi:10.1038/sj.bjc.6604011
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study FREE
P Österlund, T Ruotsalainen, R Korpela, M Saxelin, A Ollus, P Valta, M Kouri, I Elomaa and H Joensuu
Br J Cancer 97: 1028-1034; advance online publication, September 25, 2007; doi:10.1038/sj.bjc.6603990
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases FREE
C Barone, G Nuzzo, A Cassano, M Basso, G Schinzari, F Giuliante, E D'Argento, N Trigila, A Astone and C Pozzo
Br J Cancer 97: 1035-1039; advance online publication, September 25, 2007; doi:10.1038/sj.bjc.6603988
Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer FREE
T Gamucci, A M D'Ottavio, E Magnolfi, M Barduagni, A Vaccaro, I Sperduti, L Moscetti, F Belli and L Meliffi
Br J Cancer 97: 1040-1045; doi:10.1038/sj.bjc.6603982
Are ipsilateral breast tumour invasive recurrences in young (
40 years) women more aggressive than their primary tumours? FREE
B Sigal-Zafrani, M A Bollet, G Antoni, A Savignoni, A Vincent-Salomon, J-Y Pierga, R Salmon, X Sastre-Garau and A Fourquet
Br J Cancer 97: 1046-1052; advance online publication, September 18, 2007; doi:10.1038/sj.bjc.6603991
High incidence of silent venous thromboembolism before treatment in ovarian cancer FREE
T Satoh, A Oki, K Uno, M Sakurai, H Ochi, S Okada, R Minami, K Matsumoto, Y O Tanaka, H Tsunoda, S Homma and H Yoshikawa
Br J Cancer 97: 1053-1057; advance online publication, September 25, 2007; doi:10.1038/sj.bjc.6603989
Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers FREE
T Ota, N Takeshima, T Tabata, K Hasumi and K Takizawa
Br J Cancer 97: 1058-1062; advance online publication, September 25, 2007; doi:10.1038/sj.bjc.6604005
Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory FREE
P Wright, A Smith, K Roberts, P Selby and G Velikova
Br J Cancer 97: 1063-1070; advance online publication, September 25, 2007; doi:10.1038/sj.bjc.6604006
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules FREE
K M Li, L P Rivory and S J Clarke
Br J Cancer 97: 1071-1076; advance online publication, October 2, 2007; doi:10.1038/sj.bjc.6603995
Translational Therapeutics
Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1 FREE
D J A de Groot, M van der Deen, T K P Le, A Regeling, S de Jong and E G E de Vries
Br J Cancer 97: 1077-1083; doi:10.1038/sj.bjc.6604010
The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study FREE
A M E Bruynzeel, H W M Niessen, J G F Bronzwaer, J J M van der Hoeven, J Berkhof, A Bast, W J F van der Vijgh and C J van Groeningen
Br J Cancer 97: 1084-1089; doi:10.1038/sj.bjc.6603994
Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells FREE
A V Timoshenko, S Rastogi and P K Lala
Br J Cancer 97: 1090-1098; advance online publication, October 2, 2007; doi:10.1038/sj.bjc.6603993
Induction of heme oxygenase-1 by cobalt protoporphyrin enhances the antitumour effect of bortezomib in adult T-cell leukaemia cells FREE
R S Hamamura, J H Ohyashiki, R Kurashina, C Kobayashi, Y Zhang, T Takaku and K Ohyashiki
Br J Cancer 97: 1099-1105; advance online publication, September 25, 2007; doi:10.1038/sj.bjc.6604003
Molecular Diagnostics
Regulation and functional role of the Runt-related transcription factor-2 in pancreatic cancer FREE
H Kayed, X Jiang, S Keleg, R Jesnowski, T Giese, M R Berger, I Esposito, M Löhr, H Friess and J Kleeff
Br J Cancer 97: 1106-1115; advance online publication, September 18, 2007; doi:10.1038/sj.bjc.6603984
Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines FREE
E M Hurt, S B Thomas, B Peng and W L Farrar
Br J Cancer 97: 1116-1123; advance online publication, September 25, 2007; doi:10.1038/sj.bjc.6604000
Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: relationship with cell cycle regulators and prognostic implications FREE
H Gakiopoulou, P Korkolopoulou, G Levidou, I Thymara, A Saetta, C Piperi, N Givalos, I Vassilopoulos, K Ventouri, A Tsenga, A Bamias, M-A Dimopoulos, E Agapitos and E Patsouris
Br J Cancer 97: 1124-1134; doi:10.1038/sj.bjc.6603992
Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer FREE
B S Nedergaard, M Ladekarl, H F Thomsen, J R Nyengaard and K Nielsen
Br J Cancer 97: 1135-1138; doi:10.1038/sj.bjc.6604001
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients FREE
M Frattini, P Saletti, E Romagnani, V Martin, F Molinari, M Ghisletta, A Camponovo, L L Etienne, F Cavalli and L Mazzucchelli
Br J Cancer 97: 1139-1145; doi:10.1038/sj.bjc.6604009
C4.4A as a candidate marker in the diagnosis of colorectal cancer FREE
C Paret, D Hildebrand, J Weitz, A Kopp-Schneider, A Kuhn, A Beer, R Hautmann and M Zöller
Br J Cancer 97: 1146-1156; advance online publication, October 2, 2007; doi:10.1038/sj.bjc.6604012
Genetics and Genomics
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy FREE
M Varna, H Soliman, J-P Feugeas, E Turpin, D Chapelin, L Legrès, L-F Plassa, A de Roquancourt, M Espié, J-L Misset, A Janin, H de Thé and P Bertheau
Br J Cancer 97: 1157-1164; advance online publication, September 18, 2007; doi:10.1038/sj.bjc.6603937
Distinct molecular phenotype of inflammatory breast cancer compared to non-inflammatory breast cancer using Affymetrix-based genome-wide gene-expression analysis FREE
S Van Laere, I Van der Auwera, G Van den Eynden, P Van Hummelen, P van Dam, E Van Marck, P B Vermeulen and L Dirix
Br J Cancer 97: 1165-1174; advance online publication, September 11, 2007; doi:10.1038/sj.bjc.6603967
TGFBR1*6A and Int7G24A variants of transforming growth factor-
receptor 1 in Swedish familial and sporadic breast cancer FREE
B Song, S Margolin, J Skoglund, X Zhou, J Rantala, S Picelli, B Werelius and A Lindblom
Br J Cancer 97: 1175-1179; advance online publication, September 11, 2007; doi:10.1038/sj.bjc.6603961
Letters to the Editor
Optimum duration of breast cancer follow-up: a continuing controversy FREE
L Maraqa and M Lansdown
Br J Cancer 97: 1180-1181; advance online publication, September 11, 2007; doi:10.1038/sj.bjc.6603979
Reply: Optimum duration of breast cancer follow-up: a continuing controversy FREE
D A Montgomery and J M Dixon
Br J Cancer 97: 1182-1183; advance online publication, September 11, 2007; doi:10.1038/sj.bjc.6603974
Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer? FREE
W Vogel and H Surowy
Br J Cancer 97: 1184-1186; advance online publication, September 11, 2007; doi:10.1038/sj.bjc.6603977
Reply: Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer? FREE
S A Narod
Br J Cancer 97: 1187; advance online publication, September 11, 2007; doi:10.1038/sj.bjc.6603978
Corrigendum
GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours FREE
J Shamash, T Powles, W Ansell, D Berney, J Stebbing, K Mutsvangwa, P Wilson, S Asterling, S Liu, P Wyatt, S P Joel and R T D Oliver
Br J Cancer 97: 1188; doi:10.1038/sj.bjc.6604041
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
